Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial.
Saved in:
| Title: | Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial. |
|---|---|
| Authors: | Kulkarni PS; Serum Institute of India, Pune, India. Electronic address: drpsk@seruminstitute.com., Zaman K; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Desai SA; Serum Institute of India, Pune, India., Bharati S; Serum Institute of India, Pune, India., Goswami DR; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Sharmeen AT; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Rana S; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Haque W; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Khandelwal A; Serum Institute of India, Pune, India., Manney S; Serum Institute of India, Pune, India., Tyagi P; Serum Institute of India, Pune, India., Gairola S; Serum Institute of India, Pune, India., Zade JK; Serum Institute of India, Pune, India., Pisal SS; Serum Institute of India, Pune, India., Dhere RM; Serum Institute of India, Pune, India., Poonawalla CS; Serum Institute of India, Pune, India., Lamberigts C; Cerba Research NL (ViroClinics), Schaijk, Netherlands., Parulekar V; Diagnosearch Life Sciences, Thane, India., Potey AV; Serum Institute of India, Pune, India. |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2025 Oct; Vol. 25 (10), pp. 1128-1137. Date of Electronic Publication: 2025 Jun 09. |
| Publication Type: | Clinical Trial, Phase III; Equivalence Trial; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40505670 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kulkarni+PS%22">Kulkarni PS</searchLink>; Serum Institute of India, Pune, India. Electronic address: drpsk@seruminstitute.com.<br /><searchLink fieldCode="AU" term="%22Zaman+K%22">Zaman K</searchLink>; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Desai+SA%22">Desai SA</searchLink>; Serum Institute of India, Pune, India.<br /><searchLink fieldCode="AU" term="%22Bharati+S%22">Bharati S</searchLink>; Serum Institute of India, Pune, India.<br /><searchLink fieldCode="AU" term="%22Goswami+DR%22">Goswami DR</searchLink>; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Sharmeen+AT%22">Sharmeen AT</searchLink>; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Rana+S%22">Rana S</searchLink>; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Haque+W%22">Haque W</searchLink>; International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Khandelwal+A%22">Khandelwal A</searchLink>; Serum Institute of India, Pune, India.<br /><searchLink fieldCode="AU" term="%22Manney+S%22">Manney S</searchLink>; Serum Institute of India, Pune, India.<br /><searchLink fieldCode="AU" term="%22Tyagi+P%22">Tyagi P</searchLink>; Serum Institute of India, Pune, India.<br /><searchLink fieldCode="AU" term="%22Gairola+S%22">Gairola S</searchLink>; Serum Institute of India, Pune, India.<br /><searchLink fieldCode="AU" term="%22Zade+JK%22">Zade JK</searchLink>; Serum Institute of India, Pune, India.<br /><searchLink fieldCode="AU" term="%22Pisal+SS%22">Pisal SS</searchLink>; Serum Institute of India, Pune, India.<br /><searchLink fieldCode="AU" term="%22Dhere+RM%22">Dhere RM</searchLink>; Serum Institute of India, Pune, India.<br /><searchLink fieldCode="AU" term="%22Poonawalla+CS%22">Poonawalla CS</searchLink>; Serum Institute of India, Pune, India.<br /><searchLink fieldCode="AU" term="%22Lamberigts+C%22">Lamberigts C</searchLink>; Cerba Research NL (ViroClinics), Schaijk, Netherlands.<br /><searchLink fieldCode="AU" term="%22Parulekar+V%22">Parulekar V</searchLink>; Diagnosearch Life Sciences, Thane, India.<br /><searchLink fieldCode="AU" term="%22Potey+AV%22">Potey AV</searchLink>; Serum Institute of India, Pune, India. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101130150%22">The Lancet. Infectious diseases</searchLink> [Lancet Infect Dis] 2025 Oct; Vol. 25 (10), pp. 1128-1137. <i>Date of Electronic Publication: </i>2025 Jun 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Equivalence Trial; Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130150 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4457 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214733099%22">14733099 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40505670 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1473-3099(25)00215-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1128 Titles: – TitleFull: Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kulkarni PS – PersonEntity: Name: NameFull: Zaman K – PersonEntity: Name: NameFull: Desai SA – PersonEntity: Name: NameFull: Bharati S – PersonEntity: Name: NameFull: Goswami DR – PersonEntity: Name: NameFull: Sharmeen AT – PersonEntity: Name: NameFull: Rana S – PersonEntity: Name: NameFull: Haque W – PersonEntity: Name: NameFull: Khandelwal A – PersonEntity: Name: NameFull: Manney S – PersonEntity: Name: NameFull: Tyagi P – PersonEntity: Name: NameFull: Gairola S – PersonEntity: Name: NameFull: Zade JK – PersonEntity: Name: NameFull: Pisal SS – PersonEntity: Name: NameFull: Dhere RM – PersonEntity: Name: NameFull: Poonawalla CS – PersonEntity: Name: NameFull: Lamberigts C – PersonEntity: Name: NameFull: Parulekar V – PersonEntity: Name: NameFull: Potey AV IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2025 Oct Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1474-4457 Numbering: – Type: volume Value: 25 – Type: issue Value: 10 Titles: – TitleFull: The Lancet. Infectious diseases Type: main |
| ResultId | 1 |